Latest Breaking News On - Kaitlyn nealy - Page 8 : comparemela.com

MorphoSys AG: Invitation to MorphoSys Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022

MorphoSys AG: Invitation to MorphoSys Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKaitlyn nealyThomas biegiJulia neugebauerMyles cloustonExchange commissionConference callMorphosy managementMorphosy annual report

MorphoSys AG: Invitation to MorphoSys Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022

MorphoSys AG: Invitation to MorphoSys Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKaitlyn nealyThomas biegiJulia neugebauerMyles cloustonExchange commissionConference callMorphosy managementMorphosy annual report

MorphoSys Reports Preliminary Q2 2022 Monjuvi U S Sales and Updates Financial Guidance for 2022

MorphoSys Reports Preliminary Q2 2022 Monjuvi U S Sales and Updates Financial Guidance for 2022
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKaitlyn nealyThomas biegiJulia neugebauerJean paul kressMyles cloustonXencor incDrug administrationUs communicationsExchange commissionHuman immunology biosciences incHuman immunology biosciencesProduct salesChief executive officerGross margin

MorphoSys AG: MorphoSys Reports Preliminary Q2 2022 Monjuvi U S Sales and Updates Financial Guidance for 2022

Preliminary Q2 2022 Monjuvi U.S. net product sales of US$ 23.3 million (€ 21.7 million)Update of financial guidance range for 2022 Monjuvi U.S. net product sales (now US$ 90 to US$ 110 million)Update of

United statesUnited kingdomKaitlyn nealyThomas biegiJulia neugebauerJean paul kressMyles cloustonXencor incDrug administrationUs communicationsExchange commissionHuman immunology biosciences incHuman immunology biosciencesProduct salesChief executive officerGross margin

MorphoSys AG Reports Outcome of Annual General Meeting 2022

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 18, 2022 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) announced today that its shareholders approved all resolutions proposed by the Company's Management and Supervisory

United statesWendy johnsonJulia neugebauerAndrew chengMyles cloustonMarc cluzelThomas biegiKaitlyn nealyJean paul kressPricewaterhousecoopers gmbh wirtschaftsprArticles of associationCompany managementExchange commissionRestricted stock unit programSupervisory boardsAnnual general meeting